Does Kevzara Interact with Other RA Medications?
Kevzara (sarilumab), an IL-6 receptor inhibitor for rheumatoid arthritis (RA), has documented interactions with common RA drugs, primarily due to increased infection risk and altered drug levels. It carries FDA boxed warnings against use with biologic DMARDs like TNF blockers (e.g., Humira, Enbrel) or other IL-6 inhibitors (e.g., Actemra), as combinations raise serious infection risks without added benefit.[1]
Common Interactions with Methotrexate and Other DMARDs
Kevzara is often used with methotrexate (MTX), the standard first-line DMARD, but requires monitoring. MTX reduces Kevzara clearance by 20-30%, potentially increasing exposure and side effects like neutropenia. No dose adjustments are needed, but liver enzymes and blood counts must be checked regularly. With leflunomide or sulfasalazine, interactions are less pronounced but still warrant caution for overlapping hepatotoxicity.[1][2]
Risks with Biologics and JAK Inhibitors
Combining Kevzara with TNF inhibitors (adalimumab, etanercept), other biologics (rituximab, abatacept), or JAK inhibitors (Xeljanz, Rinvoq) is not recommended. These pairings amplify immunosuppression, leading to higher rates of serious infections, tuberculosis reactivation, and malignancies in trials. Live vaccines are also contraindicated during Kevzara use.[1]
What Happens with NSAIDs, Corticosteroids, or Pain Relievers?
Non-serious interactions occur with NSAIDs (ibuprofen, naproxen) or corticosteroids (prednisone), mainly elevating gastrointestinal bleeding or infection risks—use lowest effective doses. CYP3A4 inducers like rifampin lower Kevzara levels by up to 45%, possibly reducing efficacy; strong inhibitors like ketoconazole have minimal impact. No major issues with acetaminophen.[2]
How Do Doctors Manage These Interactions?
Prescribers follow RA guidelines: start Kevzara monotherapy or with MTX only, screen for infections/TB before initiation, and avoid poly-biologic therapy. Regular monitoring includes CBC, lipids, and liver function every 4-8 weeks initially. Patient RA registries show safe concurrent MTX use in most cases, with infection rates around 4-5%.[3]
[1]: Kevzara Prescribing Information (FDA)
[2]: Drugs.com - Kevzara Interactions
[3]: Arthritis.org - Kevzara Safety